GHRP-6: FDA Status and Evidence
A growth hormone releasing peptide on FDA's Category 2 list for 503B compounding. It is not FDA-approved; the clearest human effect is increased growth hormone and appetite.
Medically reviewed by Charles Kamen, MD, board-certified neurologist · ·
What the research shows
GHRP-6 raises growth hormone and, through the ghrelin receptor, strongly increases appetite. Human data are limited to short-term physiology studies. There are no outcome trials for anti-aging, body composition or recovery.
It is on the World Anti-Doping Agency prohibited list.
Frequently Asked Questions
Is GHRP-6 FDA-approved?
No. GHRP-6 is not an FDA-approved drug.
Can a pharmacy compound GHRP-6?
FDA lists GHRP-6 in Category 2 for 503B outsourcing facilities, a list of substances that may present significant safety risks. Check the live FDA lists, which change.
Why does GHRP-6 increase hunger?
It activates the ghrelin receptor, the same receptor behind normal hunger signals.
Selected Research
Peer-reviewed sources on GHRP-6. Research does not constitute a treatment recommendation; appropriateness is determined only after a medical evaluation.
Related Growth hormone support
IGF-1 LR3
An insulin-like growth factor peptide studied for recovery and growth - physician-supervised in Las Vegas.
Sermorelin
A growth-hormone-releasing peptide studied for energy, body composition, and recovery - physician-supervised in Las Vegas.
CJC-1295 & Ipamorelin
A commonly paired GHRH/GHRP peptide combination studied for recovery and body composition - physician-supervised in Las Vegas.
MK-677 (Ibutamoren)
An oral growth hormone secretagogue studied for appetite, sleep, and body composition - physician-supervised in Las Vegas.